Michael E. DeBakey VA Medical Center

Running trials

• Not yet recruiting

  ACT for Veterans With IBD and Mental Health Challenges

  NCT07397195· Source

• Not yet recruiting

  Empowerment Program to Reduce Treatment of Asymptomatic Bacteriuria in Veterans With Spinal Cord Injury

  NCT07430904· Source

• Not yet recruiting

  Novel Brain Stimulation Treatment for Neuropsychiatric Symptoms in Alzheimer's Disease

  NCT06835283· Source

• Not yet recruiting

  Metformin to Attenuate Progressive Respiratory Decline in Idiopathic Pulmonary Fibrosis

  NCT07520110· Phase 3· Source

• Recruiting

  CSP #2025 - Geriatric OUt-of-hospital Randomized MEal Trial in Heart Failure: Veterans Affairs (GOURMET-VA)

  NCT05996328· Source

• Recruiting

  Biomarker Directed Trial of Temozolomide and Stenoparib in Relapsed SCLC

  NCT06681220· Phase 1/2· Source

• Recruiting

  Randomized Clinical Trial for Ewing Amputation in the VA

  NCT05437562· Source

• Recruiting

  EZH2 Inhibitor, Tulmimetostat, and PD-1 Blockade for Treatment of Advanced Non-small Cell Lung Cancer

  NCT05467748· Phase 1/2· Source

• Recruiting

  A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)

  NCT07164443· Phase 3· Source

• Recruiting

  VR Mindfulness Training for Veterans With SCI

  NCT06587607· Source

• Recruiting

  Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

  NCT06592924· Phase 3· Source

• Recruiting

  Bacteriophage Therapy in Spinal Cord Injury Patients With Bacteriuria

  NCT06559618· Phase 1· Source

• Recruiting

  Neurobehavioral Therapy For Epilepsy And Major Depressive Disorder

  NCT06695767· Source

• Recruiting

  Implementing a Decision Support Tool to Prevent Community-Acquired Pressure Injury in Spinal Cord Injury (SCI) in the Spinal Cord Injury Clinic

  NCT06529094· Source

• Recruiting

  A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

  NCT06623422· Phase 3· Source

• Recruiting

  A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer

  NCT05563766· Phase 2· Source

• Enrolling by invitation

  Long-term Safety and Tolerability of BHV-7000

  NCT06443463· Phase 2· Source

• Active, not recruiting

  A Study Evaluating Atezolizumab, With or Without Bevacizumab, in Participants With Unresectable Hepatocellular Carcinoma and Child-pugh B7 and B8 Cirrhosis

  NCT06096779· Phase 2· Source

• Recruiting

  A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

  NCT06430801· Phase 3· Source

• Recruiting

  A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss

  NCT05593497· Phase 2· Source

• Recruiting

  Repositioning Immunotherapy in VetArans With Lung Cancer

  NCT06275360· Phase 2· Source

• Recruiting

  NAFLD Clinical Care Pathway

  NCT06671886· Source

• Recruiting

  Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study

  NCT05987241· Phase 2/3· Source

• Recruiting

  Pimavanserin for Insomnia in Veterans With PTSD

  NCT05441280· Phase 2· Source

• Active, not recruiting

  A Study of Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following TURBT

  NCT06111235· Phase 3· Source

• Recruiting

  Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI

  NCT05486572· Source

• Recruiting

  Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment

  NCT05561387· Phase 3· Source

• Recruiting

  The Peri-OPerative COlchicine to Reduce Negative Events (POPCORN) Trial

  NCT05618353· Phase 4· Source

• Recruiting

  Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes

  NCT02915198· Phase 4· Source

• Active, not recruiting

  A Study Comparing Teclistamab Monotherapy Versus Pomalidomide, Bortezomib, Dexamethasone (PVd) or Carfilzomib, Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma

  NCT05572515· Phase 3· Source

• Active, not recruiting

  Intravesical BCG vs GEMDOCE in NMIBC

  NCT05538663· Phase 3· Source

• Recruiting

  Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis

  NCT04373317· Phase 4· Source

• Recruiting

  Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.

  NCT05422911· Phase 2· Source

• Active, not recruiting

  COVID-19 Outcome Prediction Algorithm

  NCT05471011· Source

• Active, not recruiting

  Comparing Cisplatin Every Three Weeks to Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck Cancer

  NCT05050162· Phase 2/3· Source

• Active, not recruiting

  A Clinical Study Evaluating The Benefit of Adding Rucaparib to Enzalutamide for Men With Metastatic Prostate Cancer That Has Become Resistant To Testosterone-Deprivation Therapy

  NCT04455750· Phase 3· Source

• Recruiting

  High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers

  NCT05011383· Phase 2· Source

• Recruiting

  Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs

  NCT04613921· Source

• Active, not recruiting

  Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer

  NCT04787744· Phase 2/3· Source

• Active, not recruiting

  Comparing the New Anti-cancer Drug Eribulin With Chemotherapy Against the Usual Chemotherapy Alone in Metastatic Urothelial Cancer

  NCT04579224· Phase 3· Source

• Active, not recruiting

  Multi-Center Study of the Effects of Simvastatin on Hepatic Decompensation and Death in Subjects Presenting With High-Risk Compensated Cirrhosis

  NCT03654053· Phase 3· Source

• Recruiting

  Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer

  NCT04333537· Phase 2/3· Source

• Active, not recruiting

  Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III Colorectal Cancer

  NCT04137107· Phase 2/3· Source

• Active, not recruiting

  NCI COVID-19 in Cancer Patients, NCCAPS Study

  NCT04387656· Source

• Active, not recruiting

  S1827 (MAVERICK) Testing Whether the Use of Brain Scans Alone Instead of Brain Scans Plus Preventive Brain Radiation Affects Lifespan in Patients With Small Cell Lung Cancer

  NCT04155034· Phase 3· Source

• Active, not recruiting

  Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery

  NCT04068103· Phase 2/3· Source

• Recruiting

  Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG

  NCT04045665· Phase 3· Source

• Active, not recruiting

  Pentoxifylline in Diabetic Kidney Disease

  NCT03625648· Phase 4· Source

• Active, not recruiting

  Vitamin D3 With Chemotherapy and Bevacizumab in Treating Patients With Advanced or Metastatic Colorectal Cancer

  NCT04094688· Phase 3· Source

• Active, not recruiting

  Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments

  NCT04056247· Source

Showing 50 of 60.

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Prostate cancer6 recruiting
• Lung cancer5 recruiting
• Spinal cord injury4 recruiting
• Bladder cancer2 recruiting
• Coronary artery disease2 recruiting
• Crohn's disease2 recruiting
• Epilepsy2 recruiting
• Liver cirrhosis2 recruiting
• Peripheral artery disease2 recruiting
• Alzheimer disease1 recruiting
• Atrial fibrillation1 recruiting
• Childhood cancers1 recruiting
• Depression1 recruiting
• Fatty liver disease (MASLD/MASH)1 recruiting
• Gastric and oesophageal cancer1 recruiting
• Head and neck cancer1 recruiting
• Heart failure1 recruiting
• Idiopathic pulmonary fibrosis1 recruiting
• Insomnia1 recruiting
• Liver and biliary tract cancer1 recruiting
• Multiple myeloma1 recruiting
• Parkinson disease1 recruiting
• Stroke1 recruiting
• Ulcerative colitis1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Withdrawn

  Dronabinol As an Adjunct for Reducing Pain (DARP)-Texas Children's Hospital

  NCT06834997· Phase 2· Source

• Withdrawn

  Harnessing Allo-immunity to Enhance Immune Checkpoint Inhibitor Responses in Advanced NSCLC

  NCT06064279· Phase 1/2· Source

• Completed

  Diuretics and Volume Overload in Early CKD

  NCT05171686· Phase 4· Source

• Withdrawn

  Pimavanserin for Insomnia in Veterans With Posttraumatic Stress Disorder: Proof of Concept

  NCT04809116· Phase 4· Source

• Completed

  The EMBER Trial for Weight Management Engagement

  NCT05424081· Source

• Completed

  Determination and Validation of a Multi-analyte Assay for Lung Cancer Screening

  NCT04968548· Source

• Completed

  VA Video Connect in HIV Care

  NCT04055207· Source

• Completed

  Diet and Exercise Plus Metformin to Treat Frailty in Obese Seniors

  NCT04221750· Phase 3· Source

• Completed

  National Adaptive Trial for PTSD Related Insomnia

  NCT03668041· Phase 3· Source

• Completed

  A Pilot Randomized Controlled Trial for Hand Osteoarthritis

  NCT04784065· Source

• Completed

  Testosterone Therapy and Bone Quality in Men With Diabetes and Hypogonadism

  NCT03887936· Phase 4· Source

• Completed

  Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers

  NCT03768414· Phase 3· Source

• Completed

  Transfusion Trigger After Operations in High Cardiac Risk Patients

  NCT03229941· Source

• Completed

  Zenith® p-Branch® Endovascular Graft Pivotal Study

  NCT02396199· Source

• Completed

  S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer

  NCT01809691· Phase 3· Source

• Completed

  ProspeCtive, nOn-randoMized, MulticENter Clinical Evaluation of Edwards Pericardial Bioprostheses With a New Tissue Treatment Platform (COMMENCE)

  NCT01757665· Source

• Completed

  Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer

  NCT00217737· Phase 3· Source

Trial sites

• Michael E. DeBakey VA Medical Center43 trials
• Michael E. DeBakey VA Medical Center, Houston, TX31 trials
• Michael E Debakey VA Medical Center - NAVREF - PPDS1 trial
• Michael E. DeBakey VA Medical Center (Site 0197)1 trial
• Michael E. DeBakey VA Medical Center (Site 5086)1 trial

Conditions

Diseases this institution publishes on or runs trials for.

• Narcolepsy6 works · 0 trials